An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C) in patients with depression. The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to placebo in patients with depression. The secondary objectives are to evaluate the safety of saredutant, to evaluate the efficacy of saredutant on disability and quality of life in patients with depression, and to evaluate blood levels of saredutant.
Epistemonikos ID: 7a08a0e35f29b8e2351638706737c427aa0a7b99
First added on: May 04, 2024